Lupin seeks biosimilar, lung drug partners Reuters India Making copies of biotech medicines is emerging as a hot new business area for Indian pharmaceutical companies, which are seeking to move up the value curve by producing more complex and higher-margin generic products. Rival Dr.Reddy's Laboratories ... |
